Philips expands remote patient management with the introduction of Medical Tablet with advanced software
February 01 2021 - 9:00AM
Philips expands remote patient management with the introduction of
Medical Tablet with advanced software
February 1, 2021
- New solution available in North America, Europe and Japan
provides remote access to patient data to improve workflows to
better manage increases in patient volume
- Offers full remote information access, can be easily deployed
and enables a fully portable setup in emergency situations,
including COVID-19
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, today introduced
the Philips Medical Tablet, an end-to-end, easy-to-implement,
portable monitoring kit designed to help clinicians remotely
monitor larger patient populations during emergency situations,
like the COVID-19 pandemic. The Medical Tablet integrates with
Philips advanced IntelliVue XDS software to enable remote access of
patient monitoring information, allowing clinicians to care for
patients outside of the hospital setting. This solution is not tied
to a central monitoring station and can therefore be operated
through WiFi connection, making it easy to deploy and integrate
into existing clinical structures and workflows. Additionally, with
the Philips Medical Tablet, clinicians experience less exposure to
infected patients, and can increase efficiency through less
personal protective equipment (PPE) changing, ultimately improving
patient and clinician safety.
The COVID-19 pandemic has created a variety of challenges across
multiple care settings within the hospital, including higher than
normal patient volume in emergency rooms, personnel shortages,
reduced bed capacity and limited resources, particularly PPE. These
challenges often lead to overcrowding, increased clinician
workload, demand on resources and the added obstacle of trying to
create separation between infected and non-infected patients to
minimize the spread of disease.
In an effort to alleviate these challenges, hospitals are
creating temporary care settings for COVID-19 patients outside of
the hospital or in isolation wards, making remote and easily
transferable tools essential in delivering consistent and quality
care. During a time when both patient and clinician health and
safety are paramount, the Philips Medical Tablet using XDS software
can connect to multiple IntelliVue monitors in the same network,
allowing clinicians to remotely monitor multiple patients to reduce
contact as well as lessen bedside monitoring disturbances and
interruptions.
“As clinicians work to navigate increased workloads, safety
concerns, and transitions to remote care settings, they require
solutions that map to these increasingly challenging
circumstances,” said Peter Ziese, General Manager of Monitoring
Analytics at Philips. “The Philips Medical Tablet with IntelliVue
XDS software gives clinicians critical patient data like vital
signs and clinical decision support applications right at their
fingertips, empowering them to make informed care decisions no
matter where they are.”
Outside of emergency-use situations, the Philips Medical Tablet
with IntelliVue XDS software can be used as an extended screen,
working as a companion to the IntelliVue monitor to display
meaningful patient information through clinical decision support
tools. It can also act as a clinical workspace, combining patient
monitoring views and the hospital’s IT applications, allowing
clinicians to simultaneously interact across multiple systems for
enhanced patient care.
The Philips Medical Tablet, integrated with the IntelliVue XDS
software joins a growing portfolio of solutions aimed at addressing
the challenges and changes in patient care brought upon by
COVID-19. As both patient safety concerns and clinician workloads
rise, Philips’ remote patient monitoring services provide
clinicians with the tools they need to help improve patient
outcomes. Philips’ COVID-19-related solutions are designed for
rapid deployment and scalability. To learn more about the Philips
Medical Tablet please visit here.
For further information, please contact:
Anna HogrebePhilips Global Press OfficeTel.: +1 416 270
6757E-mail: anna.hogrebe@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Medical Tablet
- Physicians Consult with Philips Medical Tablet
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024